Allogene Therapeutics
ALLO
ALLO
176 hedge funds and large institutions have $582M invested in Allogene Therapeutics in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 62 increasing their positions, 49 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
15% less capital invested
Capital invested by funds: $686M → $582M (-$104M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
84% less call options, than puts
Call options by funds: $333K | Put options by funds: $2.13M
Holders
176
Holding in Top 10
1
Calls
$333K
Puts
$2.13M
Top Buyers
| 1 | +$18.8M | |
| 2 | +$7.79M | |
| 3 | +$6.2M | |
| 4 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$5.43M |
| 5 |
Primecap Management
Pasadena,
California
|
+$4.08M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$4.72M | |
| 3 | -$3.92M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$3.6M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$2.39M |